Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 56,544 |
| Receivables | 48,817 |
| Inventories | 259,127 |
| Other current assets | 67,426 |
| TOTAL | $431,914 |
| Non-Current Assets | |
| PPE Net | 217,863 |
| TOTAL | $217,863 |
| Total Assets | $852,767 |
| Liabilities | |
| Current Liabilities | |
| TOTAL | $223,525 |
| Non-Current Liabilities | |
| Long Term Debt | 113,540 |
| Other Non-Current Liabilities | 1,000 |
| TOTAL | $114,540 |
| Total Liabilities | $359,498 |
| Shareholders' Equity | |
| Retained earnings | 444,311 |
| Other shareholders' equity | 48,958 |
| TOTAL | $493,269 |
| Total Liabilities And Equity | $852,767 |